Inhaled Insulin Regimen Promising as an Alternative to Pumps and Injections in Type 1 Diabetes: Study Shows Medha Baranwal15 April 2025 9:00 AM ISTUSA: A recent 13-week clinical evaluation has demonstrated that inhaled Technosphere Insulin (TI) combined with insulin degludec offers comparable or...
Insulin Degludec: A Safer, More Effective Option for Managing Critical Illness Hyperglycemia, Study Finds Medha Baranwal22 Jan 2025 8:30 AM ISTEgypt: A recent study published in the Indian Journal of Critical Care Medicine has compared the efficacy of ultra-long-acting insulin degludec with...
Technosphere insulin and Degludec non-inferior to usual care for postprandial hyperglycemia in T1 Diabetics: Study Dr.Niharika Harsha B1 Jan 2025 9:00 AM ISTA recent study published in the journal Diabetes Care found that the combination of Technosphere insulin (TI) plus insulin degludec is non-inferior...
Weekly Insulin Efsitora Noninferior to Daily Insulin Degludec for Type 2 Diabetes Management: Phase 3 Trial Medha Baranwal19 Sept 2024 7:00 AM ISTUSA: A recent clinical trial (QWINT-2) has revealed that efsitora, a new once-weekly insulin, is as effective as the well-established once-daily...
Weekly insulin icodec as effective as daily degludec for management of type 1 diabetes: ONWARDS 6 trial Dr. Kamal Kant Kohli6 Nov 2023 8:15 PM ISTDenmark: Findings from a phase 3 clinical trial have shown once-weekly insulin icodec to be non-inferior to once-daily degludec in HbA1c reduction at...
Once-weekly insulin icodec noninferior to once-daily insulin degludec for HbA1c reduction in type 2 diabetes: ONWARDS 3 trial Medha Baranwal27 Jun 2023 10:45 AM ISTDenmark: The ONWARDS 3 randomized clinical trial showed the efficacy of once-weekly insulin icodec treatment in patients with insulin-naive type 2...
Insulin Degludec non-inferior to detemir in pregnant women with T1D Aditi27 April 2023 8:15 AM ISTResearchers have interpreted that among pregnant women with a history of type 1 diabetes, degludec is non-inferior to detemir.This article entitled...
Weekly BIF as efficacious as degludec with lower incident hypoglycaemia in type 2 diabetes patients: Lancet Medha Baranwal14 Feb 2023 11:15 AM ISTUSA: Weekly basal insulin Fc (BIF) provided similar efficacy to degludec despite higher fasting glucose targets in the BIF groups, according to...
Insulin degludec may be considered during pregnancy: CDSCO Panel tells Novo Nordisk Dr. Divya Colin2 Feb 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug...
Insulin degludec as good as insulin detemir for blood sugar control in pregnant women with type 1 diabetes Medha Baranwal13 Jan 2023 11:30 AM ISTDenmark: Insulin degludec (degludec) is non-inferior to insulin detemir (detemir) regarding safety and blood sugar control in pregnant women with type...
Use of insulin glargine in type 1 diabetes tied to reduced time in hypoglycemia after exercise: Study Medha Baranwal11 Jun 2022 10:15 AM ISTAustria: People with type 1 diabetes receiving insulin glargine U-300 (IGlar U300) had a significantly lower time spent in hypoglycemia after...
Tirzepatide bests insulin degludec for achieving blood sugar targets in type 2 diabetes: Lancet Medha Baranwal29 April 2022 9:00 AM ISTUSA: Once-weekly treatment with tirzepatide compared to insulin degludec led to superior glycemic control in patients with type 2 diabetes (T2D) on...
